FDA intends to extend the compliance dates for the unique device identification system (UDI system) requirements for Class I and unclassified device! On September 24, 2013, FDA published a final rule establishing a unique device identification system, including unique device identifier (UDI) labeling and data submission requirements (78 FR 58786) (the UDI Rule). Generally, under
Guidance for Industry: Compliance with Providing an Acceptable Unique Facility Identifier for the Foreign Supplier Verification Programs (FSVP) Regulation.
The FDA new guidance provides information on how the importers will comply with FDA’s requirement to identify themselves as the importer of a food at entry into the United States under the Foreign Supplier Verification Programs (FSVP) regulation, including the requirement to provide a unique facility identifier (UFI) recognized as acceptable by FDA. On March
European Commission (EU) approves Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to ensure safety of Medical Device.
People rely on medical device ranging from simple contact lenses to sophisticated pacemakers to improve the health and quality of life and so expect them to be safe and incorporate the latest progress in science and innovation. To reflect the substantial technological and scientific progress in this sector over the last 20 years, the European
FDA wants you to address the concern about Cyber-security – Risk Management Issue for your Medical Device!!
The need for effective cyber-security to assure medical device functionality and safety has become more important with the increasing use of wireless, Internet- and network- connected devices, and the frequent electronic exchange of medical device-related health information. FDA recognizes that medical device security is a shared responsibility between stakeholders, including health care facilities, patients, providers,
As per the requirements under the FD&C Act, FDA issued guidance on May 5, 2015 “Guidance on Providing Regulatory Submissions in Electronic Format — Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications” which established a mandatory requirement for eCTD submission for NDA, BLA, IND, ANDA, and DMF. Submissions that are not
DUNS number is now Unique Facility Identifier for Importers!! FDA Recognizes DUNS Number as Acceptable for Importer Identification!!
The U.S. Food and Drug Administration today took a step towards ensuring the accuracy of its inventory of importers responsible for meeting the requirements of the Foreign Supplier Verification Programs (FSVP) rule. The FDA issued guidance formally recognizing the Data Universal Numbering System (DUNS) number as an acceptable unique facility identifier (UFI) for FSVP. The
CDRH offers an innovative learning opportunity for new and experienced review staff. The Experiential Learning Program (ELP) is a collaborative approach to closing the knowledge gap between emerging and innovative technology and the pre-market review of the resulting medical devices. Because technology continuously evolves, it is essential that CDRH review staff members are aware of
by ALAN SCHWARTZ ABSTRACT The Medical Device Single Audit Program (MDSAP) is a new medical device auditing plan with potential for several advantages. This discussion addresses an actual MDSAP audit experience and demonstrates how the organization dealt with its complexities. The MDSAP program is described including country involvements. Audit personnel and experiences are discussed. Example
FDA classification of a device is determined by the amount of regulation necessary to provide a reasonable assurance of safety and effectiveness. The Food and Drug Administration (FDA or Agency) has identified a list of class II devices that, when finalized, will be exempt from premarket notification requirements, subject to certain limitations. FDA’s initial determination
Final Guidance on Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions
Final Guidance on Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions. This guidance document explains the principal factors that FDA considers when assessing benefits and risks of original IDE applications, IDE amendments and IDE supplements for human clinical investigations of certain medical devices to determine safety and effectiveness. The approach